Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinoma
×
Ipilimumab
×
Clear all
Filters
3
NCT03058289
2025-02-27
IT-01
Intensity Therapeutics, Inc.
Phase 1/2
Completed
111 enrolled
21 charts
NCT04151563
2023-12-19
CheckMate 79X
Bristol-Myers Squibb
Phase 1/2
Withdrawn